Zydus Lifesciences Ltd on Monday said it has received final approval from the US health regulator to manufacture and market its generic version of Azithromycin tablets used in the treatment of certain bacterial infections.
About the Author
Zydus Lifesciences Ltd on Monday said it has received final approval from the US health regulator to manufacture and market its generic version of Azithromycin tablets used in the treatment of certain bacterial infections.
